$1.78
00.00%
Pre-Market: 6:22 PM EDT
15 minutes delayed
ProQR Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ProQR Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.03 | $-0.14 | 78.6 % |
Mar 2024 | 2024-05-09 | $-0.10 | $-0.12 | 18.3 % |
Sep 2023 | 2023-11-07 | $-0.08 | $-0.09 | 11.1 % |
Jun 2023 | 2023-08-03 | $-0.11 | $-0.12 | 8.33 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $6.79M | $12.51M | -45.7 % |
Mar 2024 | 2024-05-09 | $4.83M | $3.37M | 43.4 % |
Sep 2023 | 2023-11-07 | $1.49M | $3.59M | -58.5 % |
Jun 2023 | 2023-08-03 | $1.31M | $1.35M | -2.74 % |
ProQR Therapeutics (PRQR) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.03, which beat the estimate of $-0.14.
The Actual Revenue was $6.8M, which missed the estimate of $12.5M.
Browse earnings estimates, EPS, and revenue on all stocks.